LATEST MEDICAL CANNABIS STOCK NEWS

Citizen Stash Cannabis Reaffirms its Support of the Plan of Arrangement with The Valens Company Inc.
Citizen Stash Shareholders are encouraged to submit their proxies for the Special Meeting of Shareholders and Option holders on Monday, November 1, 2021 Citizen Stash Cannabis Corp. "Citizen Stash") (formerly Experion Holdings Ltd.) (TSXV:CSC) (OTCQB:EXPFF) (FRANKFURT:MB31) today confirmed its continued support of the proposed plan of arrangement (the "Valens Transaction") with The Valens Company Inc. ("Valens"). Following... Read more
Matica Subsidiary West Island Culture Signs Supply Agreement with Ontario
Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) ("Matica" or the "Company") is pleased to announce that the Company's subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture ("West Island") has signed a Master Supply Agreement with the Ontario Cannabis Retail Corporation, doing business as the Ontario Cannabis Store (the "OCS"), which is the sole wholesale distributor of cannabis for the... Read more
Green Stock News
Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.
Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has reached an agreement (the "Agreement") with 36Eight Technologies Inc. ("36Eight"), a growing bioinformatics pharmacological healthcare data and technology company, which has developed... Read more
Entourage Health Announces Filing of Amended Financial Statements and MD&A
Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, today announces that, as a result of a continuous disclosure review conducted by staff of the Ontario Securities Commission (“OSC”), the staff of the Corporate Finance Branch requested that the Company refile its... Read more
Matica Announces Share Consolidation
Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) ("Matica" or the "Company") is pleased to announce that, pursuant to a director's resolution, the Company will be consolidating its issued and outstanding share capital on the basis of every thirty (30) old Common Shares being consolidated into one (1) new Common Share (the "Share Consolidation"). Any fractional shares remaining after giving effect to the Share... Read more
Matica Announces Name Change and Share Consolidation
Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) ("Matica" or the "Company") is pleased to announce that, in connection with the previously announced share consolidation on a thirty (30) for one (1) basis (the "Consolidation"), the Company will be changing its name to West Island Brands Inc. (the "Name Change"). The common shares are scheduled to begin trading on a post-consolidation basis at market open on... Read more
Green Stock News
Canopy Growth Announces Plan to Acquire Wana Brands, the #1 Cannabis Edibles Brand in North America
Transaction Strengthens Canopy Growth's U.S. Ecosystem and Increases U.S. Cannabis Market Exposure Upon Federal Permissibility Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC) and Mountain High Products, LLC, Wana Wellness, LLC and The Cima Group, LLC (collectively, "Wana" and each, a "Wana Entity") are pleased to announce that they have entered into definitive agreements (the... Read more
Green Stock News
Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development today provided an update on the progress and significant achievements of its lead investigational drug, QIXLEEF™. QIXLEEF™ is a botanical inhaled drug product with a fixed ratio of THC and CBD that meets USA cGMP regulatory requirements. The drug will be first... Read more
Medical Marijuana, Inc. Subsidiary Kannaway® Appoints Direct Sales Veteran Lennon Ledbetter as Vice President of Sales
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has hired Lennon Ledbetter to become the Company’s Vice President of Sales. “A company is only as strong as its executive team and... Read more
Innocan Pharma Corporation Closes C$8.2 Million Private Placement with Institutional Investors
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), today announced that it has closed its previously announced private placement of the Company's common shares (a "Common Share" and, collectively, the "Common Shares") and warrants to purchase common shares ("Common Warrants") to institutional investors for aggregate gross proceeds to the Company of C$8,227,150 million (the "Private... Read more
Green Stock News
Columbia Care Launches Legacy California Cannabis Brand, Classix, in Five New Markets Across the U.S.; Marks Industry’s Widest Multi-State Flower Brand Launch in a Single Day
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., is celebrating today’s expanded launch of Classix, a heritage California product brand, in five additional markets – Arizona, Delaware, Illinois, Massachusetts and New Jersey. “Classix is a... Read more
WEED, Inc. Creates HEMP BioSciences Inc. to Invest, Research, Cultivate and Develop New Strains & Commercial Products in the "Cannabinoids" Sector
WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), a cannabis and hemp bioresearch company based in the USA, announced today that WEED's CEO, Glenn E. Martin has completed the formation of HEMP BioSciences Inc., as an Arizona corporation wholly owned by its parent WEED, Inc. "Thanks to the Company's extensive R&D history in cannabis and hemp markets globally, we believe WEED is on the verge of another explosive... Read more
Next Green Wave Releases Q3 Results
Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", "NGW" or the "Company"), a premium seed-to-shelf craft cannabis producer, is pleased to announce the following financial update: High Level Q3 2021 Results The Company has exceeded its Q3 2021 Adjusted EBITDA* projection (originally announced HERE). In the below table, the Company has provided Revenue and Adjusted EBITDA* for the last four... Read more
Skye Bioscience Establishes New Cannabinoid Pharmaceutical Innovation Program
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has formed a new exclusive sponsored research agreement with Emerald Health Biotechnology Espana SLU (“EHBE”), focused on developing and characterizing novel molecules that can affect the... Read more
Citizen Stash Enters the Province of Nova Scotia
Citizen Stash Cannabis Corp. (the "Company" or "Citizen Stash") (TSXV:CSC) (OTCQB:EXPFF) (FRANKFURT:MB31) is pleased to announce the launch of its premium flower products into Nova Scotia where it will be available in cannabis retail stores within the province in the coming weeks. The Company's wholly owned subsidiary, Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of premium cannabis, has... Read more
Green Stock News
Aurora Announces Sponsorship of ALUS' New Acre Project to Fund Community Environmental Initiatives
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a New Acre Project sponsorship to support ALUS. The commitment is intended to fund environmental programs in the communities where Aurora facilities are located. The sponsorship creates shared value for Aurora's customers, consumers, and patients by taking action to address climate change,... Read more
Medical Marijuana, Inc. Celebrates Largest Revenue Month for Japan Division of Subsidiary Kannaway® and Manufacturing Subsidiary
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of the Company’s subsidiary Kannaway® experienced its largest revenue month in the division’s history for the month of September 2021.... Read more
Innocan Pharma Corporation Announces C$8.2 Million Private Placement with Institutional Investors
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), today announced that it has entered into securities purchase agreements for a private placement of the Company's common shares (a "Common Share" and, collectively, the "Common Shares") and warrants to purchase common shares ("Common Warrants") to institutional investors for aggregate gross proceeds to the Company of approximately... Read more
Zynerba Pharmaceuticals Announces Presentation of Poster at the 2021 American Academy of Pediatrics National Conference & Exhibition
Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced the presentation of a poster at the 2021 American Academy of Pediatrics (AAP) National Conference & Exhibition, which will be held virtually from October 8-11, 2021. A copy of the poster titled, “Longer Term Tolerability and... Read more
CV Sciences, Inc. Applauds the California Legislature for Passage of AB 45
CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, applauds the California Legislature of its passage of AB 45, which yesterday was signed into law by Governor Gavin Newson. This new law will explicitly permit the retail sale of products containing hemp-derived extracts and... Read more
Skye Bioscience Appoints Head of Regulatory Affairs & Quality Assurance and Senior Director of Research & Development
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has strengthened its management team with the appointment of Rhea Williams, MPH, as Head of Regulatory Affairs & Quality Assurance and Varun Khurana, PhD, as Senior Director of Research & Development. Rhea Williams, MPH, brings over 25 years... Read more
Green Stock News
Item 9 Labs Corp. to Acquire Colorado Dispensary, Kickstarts National Acquisition Growth Plan
Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced it has signed an Asset Purchase Agreement ("APA") for an existing dispensary license and storefront in Adams County, CO. This will be the first corporate-owned shop under its cannabis dispensary franchise brand, Unity Rd., and is... Read more
Columbia Care Announces Grand Opening of Cannabist Dispensary in Missouri; First Cannabist in the State and Ninth in the Nation
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S. announced today the first Cannabist dispensary in Missouri, located in Hermann, is now open. This marks the ninth Cannabist location and the 75th active Columbia Care dispensary in the U.S. Cannabist... Read more
Khiron Life Sciences Corp.: Invitation to the Benzinga Cannabis Capital Conference
Khiron Life Sciences Corp. (TSXV: KHRN.V) (OTCQX: KHRNF) (FSE: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, will be participating in the Benzinga Cannabis Capital Conference, which will take place on October 14 and October 15 at the Marriott Marquis hotel in New York City. Virtual access to the conference for those unable to attend in person is also available. Alvaro... Read more
Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results
Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today reported financial results for the first fiscal quarter ended August 31, 2021. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated, and presented in accordance with accounting principles generally accepted in the U.S.... Read more
Green Stock News
Khiron presents its first research study with 1,400 patients
12-month observational study results presented at the International Pain Conference in Colombia on September 25th, 2021 1st research study of its kind with a significant patient base for medical cannabis in LatAm 1,453 patients in 12-month period, serviced at Khiron's Zerenia clinics in Colombia, using Khiron's CBD and THC oral sublingual medical cannabis oils 80% patients with positive clinic response for chronic pain,... Read more
VIVO Cannabis(TM) Adds Craft Licensed Producer, Delta 9 to Online Medical Marketplace
VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced a partnership with Delta 9 Cannabis Inc ("Delta 9") to offer Delta 9 products on VIVO's Canna Farms e-commerce... Read more
Next Green Wave Eliminates All Debt
Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", "NGW" or the "Company"), a premium seed-to-shelf craft cannabis producer, is pleased to announce the following financial updates: Loan Fully Repaid As of September 30, 2021, the Company has used its cash-on-hand to fully repay the last of its outstanding debt, and as a result, the Company's only remaining liabilities on its Balance Sheet are trade... Read more
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Partnership with the Por Grace Foundation
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will partner with the non-profit organization The Por Grace Foundation. The partnership will be focused on raising awareness of the... Read more
Caroline MacCallum, MD, FRCPC, BSc Pharm, Joins PreveCeutical
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is very pleased to announce the appointment of Dr. Caroline MacCallum as a senior advisor and consultant for the Company. Dr. MacCallum will be working with our team on the development and commercialization of the Company's Cannabinoid Sol-gel products. Her specialization in internal medicine and expertise in complex pain... Read more
Green Stock News
REDUVO™ - A Major Milestone for Tetra Bio-Pharma Inc.
Tetra is gearing up to launch REDUVO™, its first cannabinoid-derived medicine, in Canada. REDUVO™ 5-year cumulative gross sales expected to reach $121M. The Company has started numerous pre-launch activities to prepare for the introduction of REDUVO™ on the Canadian Market. Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery... Read more
Fiore Cannabis Provides Corporate Updates Including Developments at Apex Cannabis Facility in Las Vegas
Fiore Cannabis (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or the "Company"), a licensed multi-state cannabis cultivator, producer and retailer, today provided a number of corporate updates including developments regarding its Apex cannabis cultivation and production facility near Las Vegas, Nevada. The Company's partner, which has an option to purchase a cannabis cultivation licence for the Apex site from Fiore upon U.S. federal... Read more
Aleafia Health Builds on Adult-use Momentum with Retailer Harvest Party
Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) hosted a second annual adult-use retailer harvest party at its outdoor cultivation facility, with over 300 cannabis store owners, managers, budtenders and industry leaders attending. The two-day conference included retailer tours at the 86 acre outdoor site in Port Perry, Ont. and education sessions featuring the company’s cultivation... Read more
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has appointed Kaitlyn Arsenault, CPA, as Chief Financial Officer. Ms. Arsenault brings over 14 years of experience in accounting, auditing, financial reporting, mergers and acquisitions, as well as business operations in the life science and... Read more
Citizen Stash Completes $1.5 Million Debenture Offering to The Valens Company and Files Information Circular in Connection with Arrangement Agreement
Citizen Stash to hold Special Meeting of Securityholders on Monday, November 1, 2021 Citizen Stash Cannabis Corp. ("Citizen Stash") (formerly Experion Holdings Ltd.) (TSXV:CSC) (OTCQB:EXPFF) (FRANKFURT:MB31) is pleased to announce the completion of the previously announced $1.5 million investment from The Valens Company Inc. ("Valens") in Citizen Stash by way of a secured convertible debenture entered into between Citizen... Read more
Green Stock News
Innocan Pharma Announces the Filing of a PCT Patent Application for its CBD Delivery System Technology in 153 Countries
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that a new patent application has been filed for Innocan's CBD Delivery System Technology, alongside the existing LTP (CBD Loaded Liposomes) and CLX (CBD Loaded Exosomes). The new patent application discloses a unique and novel delivery system allowing the controlled release of CBD into the blood stream with... Read more
Green Stock News
Khiron Life Sciences to Present at Upcoming October Investor Conferences
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is scheduled to participate in the following virtual investor conferences in October 2021: A.G.P.' S VIRTUAL FALL CONSUMER CANNABIS CONFERENCEAttending 1x1 Meetings: Tuesday, October 5th 2021 Moderator: Aaron Grey, Managing... Read more
Green Stock News
Item 9 Labs Corp. Bolsters Marketing Team with Multiple Key Hires
 Item 9 Labs Corp. (OTCQX: INLB) (the "Company"), a vertically integrated, cannabis dispensary franchisor and operator that produces premium, award-winning products, today announced that the Company has added a senior-level marketing executive and a mid-level marketing professional to its marketing team. Their focus is on managing and advancing the accelerated sales and brand momentum that the business is... Read more
Karma Beverages Launches CBD Water - Next Evolution of Premium Infused Waters Portfolio
Today, Karma Water announced the launch of Karma CBD Water. This is the first CBD beverage to launch under the Karma wellness and probiotic waters beverage portfolio and has been developed in partnership with Canopy Growth Corporation, a world-leading diversified cannabis and hemp company. Karma CBD Water is crafted with Canopy Growth's Broad Spectrum CBD distillate made from US Hemp Biomass and powered by Karma's patented... Read more
Green Stock News
Khiron reports medical cannabis prescription growth in South America and Europe
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated international cannabis leader with core operations in Latin America and Europe, is pleased to provide a corporate update on global medical cannabis operations: Medical Cannabis Latin America Medical cannabis prescriptions grew by more than 40%, from Q2 2021 Year to date medical cannabis... Read more
Next Green Wave Appoints Curtis Floyd to Its Board of Directors
Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", "NGW" or the "Company") the Company is pleased to confirm the appointment of Curtis Floyd to NGW's Board of Directors. Mr. Floyd joins the Next Green Wave Board of Directors with an outstanding track record in business, entrepreneurship and leadership. Currently, Mr. Floyd is: a practicing attorney with The Law Offices of Curtis Floyd, holding... Read more
1933 Industries Announces AGM Date and Management Appointments
1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF) (OTCQB:TGIFF), a Nevada focused cannabis consumer packaged goods company, announces that it will hold its Annual General and Special Meeting of Shareholders on Wednesday, November 17, 2021, (the "Meeting"). The details of all matters proposed to be put before the shareholders at the Meeting are set forth in the management information circular sent to... Read more
Shareholders Approve Corporate Changes at AGM
Tree of Knowledge International Corp., ("TOKI") listed on the Canadian Securities Exchange (the "CSE") under the trading symbol "TOKI", is pleased to announce that shareholders have approved certain corporate changes, as described in the Information Circular of TOKI dated August 19, 2021. During course of business at the Special and Annual General Meeting, TOKI Shareholders approved the 2021 Stock Option Plan of the... Read more
Green Stock News
Khiron's Announces Resignation of Chief Financial Officer Swapan Kakumanu of RTB LLP appointed as Interim CFO
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announced that Joel Friedman, has resigned as Chief Financial Officer of the Company for personal reasons. Khiron's board of directors has appointed Swapan Kakumanu of RTB LLP to the role of Interim CFO, effective... Read more
Columbia Care Celebrates Transition to Cannabist in Downtown Boston Co-Located Adult-Use and Medical Dispensary
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today it has received approval from the Cannabis Control Commission (CCC) and the Boston Cannabis Board (BCB) to commence operations as Cannabist at 21 Milk Street in downtown Boston, its co-located adult-use and medical dispensary previously known as Patriot Care. Cannabist Boston is one of three... Read more
Columbia Care to Report Third Quarter 2021 Results on Friday, November 12, 2021
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the third quarter ended September 30, 2021 before US financial markets open on Friday, November 12, 2021. Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EST to discuss financial and operating... Read more
Skye Bioscience Announces Closing of $7.0 Million Registered Direct Offering
Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, today announced the closing of its previously announced registered direct offering for the purchase and sale of 77,777,779 shares of its common stock (or common stock equivalents in lieu... Read more
Green Stock News
Aurora Cannabis Launches its First Medical CBD Product in Uruguay
Bidiol is the only full-spectrum cannabis oil that is fully produced domestically Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has launched Bidiol, the first medical cannabis oil in Uruguay that is wholly produced domestically. The CBD oil is available in 3% and 10% concentrations and comes in 10mL and 30mL bottles, available in pharmacies... Read more
Green Stock News
Unity Rd. Vice President and Franchise Partner to Present at MLive Cannabis Insights Event on October 7
 Unity Rd., the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), continues to lead at the forefront of the industry. As part of the brand's commitment to cannabis education and franchise expansion, Unity Rd. will be presenting at the virtual MLive Cannabis Insights event on Thursday, October 7, which kicks off at 4:00 p.m. EDT. The presentation will include a live Q&A with Unity Rd.'s VP of... Read more
BIPOCANN, Virginia Minority Cannabis Coalition, Nolef Turns and Columbia Care Join Forces to Drive Social Equity Opportunities in Virginia Cannabis Industry
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today it is partnering with three organizations – BIPOCANN, Virginia Minority Cannabis Coalition (VMCC) and Nolef Turns – to offer social equity-driven resources for the developing cannabis community in Virginia. This group of partners is dedicated to ensuring that Virginia’s BIPOC community has... Read more
Columbia Care Commences Cultivation Operations at 34-Acre Long Island, New York Facility; Prepares for Upcoming Introduction of Whole Flower Program
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., has received approval from the New York State Department of Health to commence cultivation and processing operations at its new facility in eastern Long Island, New York. The first harvest is planned... Read more
CannAmerica Announces Extension and Provides Update Regarding Management Cease Trade Order
CannAmerica Brands Corp. (CSE:CANA) (OTC:CNNXF) (CNSX:CANA.CN) ("CannAmerica" or the "Company")  announces that the British Columbia Securities Commission (the "BCSC") has granted it an extension for its management cease trade order ("MCTO").  The MCTO was originally issued by the BCSC, effective as of August 6, 2021 and ending on September 28, 2021, in connection with the delay by the Company in filing its... Read more
Green Stock News
Item 9 Labs Corp. to Present at A.G.P.'s Virtual Fall Consumer Cannabis Conference October 5
Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced it will participate in the A.G.P. Virtual Fall Consumer Cannabis Conference on Tuesday, October 5, 2021. The conference features up to 30 select companies in the cannabis industry and will be attended by approximately 200... Read more
Aurora Cannabis Announces Fiscal 2021 Fourth Quarter Results
#1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross Margin before FVA of 68% Business Transformation Plan on Track; Reiterates Annual Cost Savings of $60 Million to $80 Million, Providing Clear Pathway to Adjusted EBITDA Profitability Balance Sheet Remains Strong with $440.9 Million of Cash at June 30, 2021; Working Capital Improves by $404.3... Read more
Skye Bioscience Announces $7.0 Million Registered Direct Offering
Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, today announced that it has entered into securities purchase agreements with several institutional investors, for the purchase and sale in a registered direct offering of 77,777,779 shares... Read more
Harvest One Announces Warrants Issued for Consulting Services
Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF) ("Harvest One" or the "Company"), a uniquely positioned cannabis-infused and non-infused consumer packaged goods ("CPG") leader, announces that further to the press release of the Company dated July 26, 2021, relating to the strategic advisory and consulting services to the Company (the "Consulting Services") to be provided by an arm's length service provider, Jonathan... Read more
Green Stock News
Innocan Pharma Announces the Filing by Ramot at Tel Aviv University of an International Patent Application for its Unique Cannabinoids Loaded Exosome Delivery Platform (CLX)
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), hereby announces the filing by Ramot of a new patent application for a unique Cannabinoids exosome delivery platform - CLX, developed by Ramot and their researchers from Tel Aviv University. InnoCan holds worldwide exclusive option agreement to develop and commercialese the CLX and noticed Ramot on the intention to execute the... Read more
Green Stock News
Unity Rd. Inks Deals for New Jersey and Virginia; Announces Maine Expansion
Unity Rd., the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), announced today the signing of its newest agreements for New Jersey and Virginia alongside continued expansion across the Northeast region. The brand's growth strategy is twofold, including both helping interested entrepreneurs enter the complex industry while also partnering with existing dispensary owners via its Local Alliance Program. The... Read more
Green Stock News
Ontario Cannabis Stores to Sell 3 New Products from THC BioMed
THC BioMed Intl Ltd. ("THC BioMed" or the "Company") is pleased to announced that 3 new THC BioMed products are to be listed and sold through the Ontario Cannabis Stores: Dragon's Lettuce dried cannabis, THC Kiss Cannabis Biscuits (Cocoa) and THC Kiss Cannabis Biscuits (Cinnamon.) Dragon's Lettuce We are pleased to introduce Dragon's Lettuce into Ontario. It's our most potent sativa landrace strain. It is cultivated... Read more
Green Stock News
Item 9 Labs Corp.'s Dispensary Franchise Expands NE Footprint into 2 New States
Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated, cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced continued development of its cannabis dispensary franchise brand, Unity Rd., across the Northeastern United States. The industry trailblazer signed agreements for New Jersey and Virginia alongside continued expansion across the Northeast... Read more
Green Stock News
Zelira™ Launches RAF FIVE™ Acne Treatment Products Through Its Dermatology Focused Subsidiary
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the research and development of clinically validated cannabinoid medicines, is pleased to announce the US launch of the Zelira Dermatology Business' first product line, RAF FIVE™, through its dermatology subsidiary Ilera Derm LLC ("Zelira Dermatology"). The five-product RAF FIVE™ line consists of the Wash Away Gel Cleanser Acne Treatment,... Read more
Green Stock News
THC BioMed Receives Purchase Orders from 30 Dispensaries in the Province of Manitoba
THC BioMed Intl Ltd. ("THC BioMed" or the "Company") is pleased to announced that it has received orders from 30 dispensaries in the province Manitoba. The Company is also pleased to announce that it has begun shipping THC KISS cannabis edibles and dried cannabis to those dispensaries. The website thckiss.buzz will be updated to add the Manitoba dispensaries to the list of dispensaries carrying THC BioMed... Read more
Tilray to Announce First Quarter Fiscal 2022 Financial Results on October 7, 2021
Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY; TSX: TLRY) announced that the Company will release financial results for its first quarter fiscal 2022 ended August 31, 2021 before financial markets open on Thursday, October 7, 2021. Tilray executives will host a conference call and live audio webcast to discuss these results at 8:30 am Eastern Time, details of which are provided below. Live Conference Call... Read more
PURA To Launch Farmersville Hemp Brand Marketing Campaign In Q4
Puration, Inc. (OTC Pink: PURA) (“PURA”) has launched a hemp industry-wide strategic initiative to collectively market for multiple hemp growers and processors under a single brand name - Farmersville Hemp. PURA has already forged partnerships with Alkame Holdings, Inc. (OTC Pink: ALKM), North American Cannabis Holdings, Inc. (OTC Pink: USMJ) and PAO Group, Inc. (OTC Pink: PAOG).  Early in Q4, PURA intends to... Read more
Skye Bioscience Announces THCVHS Late-Breaking Preclinical Abstracts Selected by American Association of Pharmaceutical Scientists Meeting PharmSci 360
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, announced today its research partner, the University of Mississippi will present late-breaking preclinical data evaluating different nanoemulsion formulations of its prodrug of tetrahydrocannabinol (THC), THCVHS, in addition to the superiority of... Read more
Body and Mind Commences Michigan Vertical Market Expansion
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operator focused on limited license markets, is pleased to report plans to enter the Michigan market with fully funded dispensary, cultivation and production facilities. BaM, through wholly owned subsidiaries, has leveraged its expertise of navigating licensing and approval processes gained with other state and local authorities, adding... Read more
Zynerba Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference
Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Armando Anido, Chairman and Chief Executive Officer of Zynerba, will participate in a fireside chat during the 2021 Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 11:20 a.m. ET. Investors... Read more
Love Hemp Group PLC Announces Change of Registered Office
Love Hemp Group PLC (AQSE:LIFE) (OTCQB:WRHLF), one of the UK's leading CBD and hemp product suppliers, announces that it has changed its registered office to Suite 1, 15 Ingestre Place, London, W1F 0DU from 14 September 2021. For further information please visit: www.lovehempgroup.com or contact: Love Hemp Group Andrew MaleChairman & Director Anna Legge Chief Communications Officer +44 (0) 7926 397... Read more
Aurora Cannabis Reschedules Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings to Monday, September 27, 2021
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results for its fourth quarter and full fiscal year 2021 to Monday, September 27, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the fourth quarter... Read more